StockData
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc. (FHTX) stock

FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30
$1.83+0.04 (+2.23%)

Close on Nov 17, 2026Market cap $108.68MP/E –Yield –

Foghorn Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Foghorn Therapeutics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$19.65M+30.1%
FY2019Dec 31, 2019$15.11M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$20.00M+35.2%
Q2 FY2021Jun 30, 2021$20.00M+32.3%
Q1 FY2021Mar 31, 2021$20.00M–
Q4 FY2020Dec 31, 2020$19.65M–
Q3 FY2020Sep 30, 2020$14.79M–
Q4 FY2019Dec 31, 2019$15.11M–

More Foghorn Therapeutics figures

See a number that looks wrong?